首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Emerging Trichosporon asahii in elderly patients: Epidemiological and molecular analysis by the DiversiLab system
【24h】

Emerging Trichosporon asahii in elderly patients: Epidemiological and molecular analysis by the DiversiLab system

机译:老年患者中出现的Trichosporon asahii:通过DiversiLab系统进行的流行病学和分子分析

获取原文
获取原文并翻译 | 示例
           

摘要

Trichosporon asahii has been recognized as an emerging opportunistic agent for invasive infections, mainly in immunocompromised patients. Urinary tract infections by this pathogen may also occur, especially in patients with urinary obstruction or those undergoing vesical catheterization and antibiotic treatment. Many outbreaks of Trichosporon spp. have been detected after urinary catheter manipulations. We report the molecular-epidemiological characterization of T. asahii in our institution using the DiversiLab system for the molecular strain typing and compare three different methods for susceptibility testing. Our results present T. asahii as an emergent pathogen in elderly patients with urinary drainage devices that can be adequately treated with triazoles, with voriconazole being the most active. Broth dilution and Vitek 2 had good concordance, while Etest showed more discrepancies. In addition, the DiversiLab system for clonal strain typing may be a useful tool for fast and accurate management of nosocomial outbreaks.
机译:毛孢曲霉已被公认为是一种针对侵袭性感染的新兴机会药物,主要用于免疫功能低下的患者。也可能发生这种病原体的尿路感染,尤其是在有尿路阻塞的患者或接受膀胱导管插入术和抗生素治疗的患者中。 Trichosporon spp的许多暴发。在导尿管操作后已被检测到。我们报道了在我们机构中使用DiversiLab系统进行分子菌株分型的麻黄T. asahii的分子流行病学特征,并比较了三种不同的药敏试验方法。我们的研究结果表明,浅色T. asahii是老年患者的尿道引流装置中的一种新兴病原体,可以用三唑类药物充分治疗,其中伏立康唑最为活跃。肉汤稀释液和Vitek 2具有良好的一致性,而Etest显示出更多差异。此外,用于克隆菌株分型的DiversiLab系统可能是用于快速准确地管理医院暴发的有用工具。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号